Prolia vs Forteo
A side-by-side look at two bone health medications advertised on TV. Informational only — not medical advice.
| US Prolia | US Forteo | |
|---|---|---|
| Generic name | denosumab | teriparatide |
| Drug class | RANKL Inhibitor (Biologic) | Parathyroid Hormone Analog |
| Treats | Osteoporosis | Osteoporosis |
| Category | Bone Health | Bone Health |
| Manufacturer | Amgen | Eli Lilly |
| Year approved | 2010 | 2002 |
| FDA warning | Moderate warnings | Moderate warnings |
| Est. TV ad spend | $120M | — |
| Common side effects | Low blood calcium, Serious infections, Back and joint pain, Skin reactions | Dizziness, Leg cramps, Nausea, Joint pain |
Frequently asked questions
Is Prolia or Forteo better?
Neither is universally "better." Prolia (denosumab) and Forteo (teriparatide) are both used for bone health, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Prolia and Forteo?
Prolia is a RANKL Inhibitor (Biologic) made by Amgen, while Forteo is a Parathyroid Hormone Analog made by Eli Lilly. See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Prolia has the larger estimated TV advertising budget of the two.